1. Home
  2. Live Updates
  3. Iosimilar

Live Breaking News & Updates on Iosimilar

Stay informed with the latest breaking news from Iosimilar on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Iosimilar and stay connected to the pulse of your community

Lyophilization Services for Biopharmaceuticals Global

Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The

Japan , China , South-korea , Dublin , Ireland , Millrock , United-kingdom-general- , United-kingdom , France , Italy , Berkshire , Spain

Global Biobetters Market Analysis to 2034 by Drug Class,

Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The

United-states , Japan , Germany , Canada , South-korea , United-kingdom , Italy , India , Russia , China , France , Dublin

US Pharmaceutical Market Review 2020-2023 and Forecast

Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The

Dublin , Ireland , France , United-states , French , American , Eli-lilly , Biologics-biosimilars , Abbvie-inc , National-health-service , Vertex-pharmaceuticals-inc , Johnson

Charting New Paths: Non-TNF's Evolving in Rheumatoid

Although crowded, the RA market contains clear pathways for existing players and new entrants to navigate the evolving landscape and expand their market...

Sanofi-regeneron-kevzara , Abbvie-humira , Eli-lilly-olumiant , Genentech-actemra , Amgen-enbrel , Abbvie-rinvoq , Spherix-network , Linkedin , Spherix-global-insight , Patient-chart-dynamix , Rheumatoid-arthritis , Eli-lilly

Alvotech settles with J&J to launch Stelara biosimilar in Europe, Canada

The deals allow Alvotech's biosimilar, or near copies of a biological drug, to enter the Canadian market in the first quarter of this year and Japan in May. Entry to the first European markets is expected after late July. Stelara has been J&J's top-selling drug since 2019, but its key patents began to expire last year.

Bengaluru , Karnataka , India , Canada , United-states , Japan , Israel , Canadian , Israeli , Shilpi-majumdar , Leroy-leo , Shounak-dasgupta

Microfluidic Modulation Spectroscopy analysis of Trastuzumab and biosimilars: Structural integrity and stability assessment

This article presents a detailed investigation of Trastuzumab and its biosimilars, focusing on their structural integrity and stability.

Belgium , Brussels , Bruxelles-capitale , United-kingdom , Trastuzumab-herceptin , Maria-osipova , Waters-corporation , Structir-lab , Wood-centre , Technology-venture-partners , Journal-of-pharmaceutical-sciences , Blackwell

Celltrion Launches 80 Mg YUFLYMA (Adalimumab-aaty) In The U.S. - Healthcare

On January 17, 2024, Celltrion announced the U.S. launch of a new, 80 mg/0.8 ml dosage strength of its HUMIRA® biosimilar, YUFLYMA® (adalimumab-aaty). As we previously reported...

Mondaq , Abbvie , Dalimumab , Iosimilar , Elltrion , Umira , Aunch , Uflyma , Food , Rugs , Ealthcare

Global Biosimilars and Biologics Market Surges: $46.11

Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The

Dublin , Ireland , Merck-kgaa , Biocon , Roche-ltd , Celltrion-inc , Company-profiles , Pfizer-inc , Eli-lilly-co , Mylan-inc , Amgen-inc

Biotech Startup Wants Insulin More Affordable: How Can 'Biosimilar' Make a Difference?

For those with diabetes, insulin is just like a part of the body that they need every time. However, patients are hampered by its price increase, so a startup decided to create its version of cheap insulin.

United-states , Houston , Texas , Canada , Cameron-owen , Sergej-djuranovic , Joseph-henry , Dennis-klicker , Tech-times , Making-insulin-cheaper , Biotech-startup-wants , Make-insulin-more-affordable

Biocon Biologics, Sandoz sign pact to distribute adalimumab biosimilar Humira in Japan

Adalimumab BS for subcutaneous injection is a biosimilar of Humira, offering therapeutic solutions for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease and ulcerative colitis

Japan , Japanese , Biocon-biologics , Biocon-ltd , Fujifilm-kyowa-kirin-biologics-co-ltd , Biocon-biologics-ltd , Biologics-ltd , Adalimumab-biosimilar-market-size , Biocon-biologic , Biocon , Iocon-biologics , Apan